Woodline Partners LP - Q4 2013 holdings

Add to watchlist

All
New
Buy
Sell
Exit
Unchanged
 Value Shares↓ Weighting
No holdings reported for quarter Q4 2013
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
LILLY ELI & CO19Q2 20242.5%
TELEFLEX INCORPORATED19Q2 20241.1%
VISHAY INTERTECHNOLOGY INC18Q2 20241.9%
ICU MED INC18Q2 20240.9%
JOHNSON & JOHNSON17Q2 20244.1%
REGENERON PHARMACEUTICALS17Q2 20242.0%
ZIMMER BIOMET HOLDINGS INC17Q2 20241.2%
REVOLUTION MEDICINES INC17Q2 20241.2%
VIAVI SOLUTIONS INC17Q2 20241.0%
ALLOGENE THERAPEUTICS INC17Q2 20241.0%

View Woodline Partners LP's complete holdings history.

Latest significant ownerships (13-D/G)
Woodline Partners LP Q4 2013 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Calidi Biotherapeutics, Inc.February 12, 2024125,0000.4%
Opy Acquisition Corp. IFebruary 12, 2024? ?
Vera Therapeutics, Inc.February 12, 20241,140,6322.2%
Ascendant Digital Acquisition Corp. IIIFebruary 10, 20231,286,0004.3%
Senti Biosciences, Inc.February 10, 2023? ?
Dynamics Special Purpose Corp.February 11, 20222,000,0008.4%
Eledon Pharmaceuticals, Inc.February 11, 2022685,2734.8%
MARKETWISE, INC.Sold outFebruary 11, 202200.0%
Ascendant Digital Acquisition Corp.February 16, 20214,008,7709.7%
Eledon Pharmaceuticals, Inc.February 16, 2021814,7565.4%

View Woodline Partners LP's complete significant-ownership history.

Latest filings
TypeFiled
N-PX2024-08-30
13F-HR2024-08-14
13F-HR2024-05-15
13F-HR2024-02-14
SC 13G/A2024-02-12
SC 13G/A2024-02-12
SC 13G2024-02-12
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15

View Woodline Partners LP's complete filings history.

All filings

View complete filings history.

Compare quarters

Export Woodline Partners LP's holdings

CSVXLS